SEER - Seer Bio Sales Growth YoY (Last 12 Months)

Sales of Proteograph systems in biotech laboratories are driving current momentum, complemented by a steady cash flow from recurring reagent supplies for Seer, Inc. (SEER). The relative sales growth over a 12-month period compared to last year demonstrates business dynamics, where the latest parameter stands at -14.60. Visionary leadership with expertise in proteomics is simplifying data workflows to advance personalized medicine.
Summary analytical data breakdowns for Seer (SEER)

This indicator measures the annual revenue growth rate over a rolling period, smoothing out quarterly volatility to assess the actual expansion of the business. By analyzing the year-over-year dynamics of commercial revenues over a rolling year, an investor can compare the sales growth of protein analysis tools against high R&D expenses, which is critical given the negative cash flows of Seer, Inc. (SEER).